News - Canakinumab Injection

Filter

Current filters:

Canakinumab Injection

Popular Filters

Novartis’ Ilaris provides substantial symptom relief in 84% of patients with most serious form of childhood arthritis

19-09-2011

Swiss drug major Novartis (NOVO: VX) announced positive results of the first pivotal Phase III trial…

Anti-Arthritics/RheumaticsCanakinumab InjectionIlarisNovartisPharmaceuticalResearch

Company Spotlight

Fibrotech

Fibrotech

Back to top